BioPorto Diagnostics AS:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioPorto Diagnostics AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6401
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and matched antibody pairs, among others. It also offers cell biology products, NGAL rapid ELISA Kit and Gc-globulin action free ELISA Kit, among others. BioPorto dDiagnostics offers various antibodies with specificity within medical specialties such as obesity, diabetes and primary immune deficiency. The company provides NGAL Test a diagnostic acute kidney injury biomarker which is measured in both human urine and plasma. It markets its products through sales channels and partners. BioPorto Diagnostics is headquartered in Copenhagen, Denmark.

BioPorto Diagnostics AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioPorto Diagnostics AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioPorto Diagnostics AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioPorto Diagnostics AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioPorto Diagnostics AS, Medical Equipment, Deal Details 10
Partnerships 10
BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 10
BioPorto Enters into Distribution Agreement with Roche Diagnostics 11
Equity Offering 12
BioPorto Diagnostics to Raise USD6.6 Million in Private Placement of Shares 12
BioPorto Diagnostics Raises USD3.2 Million in Private Placement of Shares 13
BioPorto Raises USD4.2 Million in Rights Offering of Shares 14
BioPorto Diagnostics Completes Rights Offering Of Shares For US$12.6 Million 15
BioPorto Diagnostics Completes Public Offering Of Shares For US$2 Million 16
BioPorto Diagnostics Completes Private Placement Of Shares For US$2 Million 17
BioPorto Diagnostics AS – Key Competitors 18
BioPorto Diagnostics AS – Key Employees 19
BioPorto Diagnostics AS – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 16, 2018: BioPorto Group: Interim Report, Second Quarter 2018 21
May 03, 2018: BioPorto Reports First Quarter 2018 Results 23
Nov 07, 2017: BioPorto Announces Interim report, third quarter of 2017 24
Aug 10, 2017: BioPorto: Interim report, second quarter of 2017 25
May 04, 2017: BioPorto: Interim report, first quarter of 2017 26
Corporate Communications 27
Apr 18, 2018: BioPorto Names Ole Larsen As CFO 27
Jan 16, 2018: BioPorto Diagnostics: Changes in the Board of Directors 28
Jan 04, 2018: BioPorto: Changes in the Board of Directors 29
Product News 30
Jan 22, 2018: Launch of New Oxyntomodulin Antibodies (OXM) 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
BioPorto Diagnostics AS, Medical Equipment, Key Facts 2
BioPorto Diagnostics AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioPorto Diagnostics AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioPorto Diagnostics AS, Deals By Market, 2012 to YTD 2018 8
BioPorto Diagnostics AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 10
BioPorto Enters into Distribution Agreement with Roche Diagnostics 11
BioPorto Diagnostics to Raise USD6.6 Million in Private Placement of Shares 12
BioPorto Diagnostics Raises USD3.2 Million in Private Placement of Shares 13
BioPorto Raises USD4.2 Million in Rights Offering of Shares 14
BioPorto Diagnostics Completes Rights Offering Of Shares For US$12.6 Million 15
BioPorto Diagnostics Completes Public Offering Of Shares For US$2 Million 16
BioPorto Diagnostics Completes Private Placement Of Shares For US$2 Million 17
BioPorto Diagnostics AS, Key Competitors 18
BioPorto Diagnostics AS, Key Employees 19

List of Figures
BioPorto Diagnostics AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioPorto Diagnostics AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioPorto Diagnostics AS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioPorto Diagnostics AS:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cox Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Cox Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cox Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Little Caesar Enterprises Inc:企業の戦略・SWOT・財務分析
    Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Deutsche Biotech Innovativ AG (VUA)-製薬・医療分野:企業M&A・提携分析
    Summary Deutsche Biotech Innovativ AG (DBI), formerly Venetus Beteiligungen AG is a biotechnology company that develops drug candidates on indications sepsis and cancer. The company’s products comprise Adrecizumab, DB1RA and AB2302. It diagnostic based drug development approach and offers identifica …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Micell Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Vostok New Ventures Ltd (VNV SDB):企業の財務・戦略的SWOT分析
    Summary Vostok New Ventures Ltd (Vostok New Ventures), formerly Vostok Nafta Investment Ltd, is an investment company that identifies and invests in assets. The company carries out partial and complete liquidation of holding and group’s holding companies. It identifies and invests in unlisted compan …
  • s.a. D’leteren n.v.:企業の戦略・SWOT・財務情報
    s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report Summary s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Maruzen Petrochemical Co Ltd:企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • SGS SA (SGSN):企業の財務・戦略的SWOT分析
    SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Abion Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abion Inc (Abion) is a biopharmaceutical company that conducts research activities to develop biopharmaceutical drugs and companion diagnostic systems for the treatment of incurable diseases. The company offers preclinical phase products such as ABN101, ABN301, ABN302, ABN401, and others. It …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • RP Management LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary RP Management LLC (RP Management) is a life sciences financing company that offers biopharmaceutical products. The company’s products include thalomid, myozyme, lexiscan, rituxan, atripla, lyrica, prezista, letairis, januvia, onglyza, neupogen, rotateq, cubicin, savella, and others. It also …
  • Meridian Energy Limited:企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MPC Munchmeyer Petersen Capital AG (MPCK):企業の財務・戦略的SWOT分析
    Summary MPC Munchmeyer Petersen Capital AG (MPC), a subsidiary of MPC Munchmeyer Petersen & Co GmbH, is an asset and investment management firm. The firm business segments include infrastructure, real estate and shipping. Its real estate business concentrates on micro living or student housing. Its …
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Itron Inc (ITRI):電力:M&Aディール及び事業提携情報
    Summary Itron Inc (Itron) is a technology and services company, which enables utilities and cities to provide critical infrastructure services. It offers solutions that help measure, manage and analyze energy and water use. The company’s solutions include metering systems, standard meters, next-gene …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kracie Holdings Ltd:企業の戦略的SWOT分析
    Kracie Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PartnerRe Ltd.:企業の戦略・SWOT・財務情報
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆